United States Biotechnology & Medical Research

Akebia Therapeutics Inc (AKBA)

Track

Track

Akebia Therapeutics recently observed insider trading activity involving CFO Erik Ostrowski, who executed a sale of shares totaling approximately $124,401. This follows a period where the company reported positive results in its latest earnings report. The stock price remains near its fifty-two-week low, reflecting limited volatility over the past ninety days.
Ticker: AKBA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Akebia Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ostrowski Erik SVP, CFO, CBO & Treasurer Officer
Transaction date
Sale
Price
391.03
Quantity 93,061 -40.3%
Value US$4,036,686
Ostrowski Erik Officer Officer
Transaction date
Proposed sale
Price
295.54
Quantity 31,119
Value US$701,740
3.7
Butler John P. CEO and President Executive Director
Transaction date
Purchase
Price
21.16
Quantity 34,867 +35.9%
Value US$3,910,943
Malabre Richard C SVP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 13,382 -4.3%
Value US$18,601
Grund Nicholas Chief Commercial Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 31,244 -5.3%
Value US$43,429
Rucci Carolyn M. SVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 27,544 -4.5%
Value US$38,286
Rucci Carolyn M. SVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 25,382 -4.0%
Value US$35,281
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 20,701 -2.1%
Value US$28,774
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 25,375 -2.6%
Value US$35,271
3.7
Butler John P. CEO and President Executive Director
Transaction date
Planned sale
Price
1.39
Quantity 83,689 -2.5%
Value US$116,328
3.7
Butler John P. CEO and President Executive Director
Transaction date
Planned sale
Price
1.39
Quantity 114,891 -3.5%
Value US$159,698
3.7
Butler John P. CEO and President Executive Director
Transaction date
Planned sale
Price
1.39
Quantity 96,065 -2.8%
Value US$133,530
Malabre Richard C SVP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 13,382 -4.3%
Value US$18,601
Malabre Richard C SVP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 36,142 -10.4%
Value US$50,237
Grund Nicholas Chief Commercial Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 31,244 -5.3%
Value US$43,429
Grund Nicholas Chief Commercial Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 53,585 -8.3%
Value US$74,483
Ostrowski Erik SVP, CFO, CBO & Treasurer Officer
Transaction date
Planned sale
Price
1.39
Quantity 34,951 -4.9%
Value US$48,582
Rucci Carolyn M. SVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 27,544 -4.5%
Value US$38,286
Rucci Carolyn M. SVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 25,382 -4.0%
Value US$35,281
Rucci Carolyn M. SVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 16,846 -2.6%
Value US$23,416
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 20,701 -2.1%
Value US$28,774
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 25,375 -2.6%
Value US$35,271
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.39
Quantity 21,582 -2.1%
Value US$29,999
3.7
Butler John P. CEO and President Executive Director
Transaction date
Planned sale
Price
1.39
Quantity 83,689 -2.5%
Value US$116,328
3.7
Butler John P. CEO and President Executive Director
Transaction date
Planned sale
Price
1.39
Quantity 114,891 -3.5%
Value US$159,698
3.7
Butler John P. CEO and President Executive Director
Transaction date
Planned sale
Price
1.39
Quantity 96,065 -2.8%
Value US$133,530
3.7
Butler John P. CEO and President Executive Director
Transaction date
Planned sale
Price
1.39
Quantity 46,660 -1.3%
Value US$64,857
Ostrowski Erik Officer Officer
Transaction date
Proposed sale
Price
1.39
Quantity 34,951
Value US$48,739
Grund Nicholas Officer Officer
Transaction date
Proposed sale
Price
1.39
Quantity 84,829
Value US$118,294
3.6
Burke Steven Keith Officer Officer
Transaction date
Proposed sale
Price
1.39
Quantity 67,658
Value US$94,349
3.7
Butler John P. Officer Officer
Transaction date
Proposed sale
Price
1.39
Quantity 341,305
Value US$475,950
Rucci Carolyn M. Officer Officer
Transaction date
Proposed sale
Price
1.39
Quantity 69,772
Value US$97,297
Ostrowski Erik SVP, CFO, CBO & Treasurer Officer
Transaction date
Planned sale
Price
3.67
Quantity 41,314 -7.6%
Value US$151,622
Malabre Richard C SVP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
4.01
Quantity 15,000 -5.3%
Value US$60,150
Malabre Richard C SVP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
3.53
Quantity 13,334 -4.8%
Value US$47,069
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.83
Quantity 7,144 -0.9%
Value US$13,074
3.7
Butler John P. CEO and President Executive Director
Transaction date
Planned sale
Price
1.83
Quantity 46,409 -1.8%
Value US$84,928
3.6
Burke Steven Keith Officer Officer
Transaction date
Proposed sale
Price
1.83
Quantity 7,144
Value US$13,086
3.7
Butler John P. Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.83
Quantity 46,409
Value US$85,007
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Planned sale
Price
2.10
Quantity 27,236 -3.2%
Value US$57,196
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Planned sale
Price
2.10
Quantity 23,270 -2.7%
Value US$48,867
Grund Nicholas Chief Commercial Officer Officer
Transaction date
Planned sale
Price
2.10
Quantity 55,621 -11.2%
Value US$116,804
Malabre Richard C SVP, Chief Accounting Officer Officer
Transaction date
Planned sale
Price
2.10
Quantity 30,202 -9.7%
Value US$63,424
3.7
Butler John P. CEO and President Executive Director
Transaction date
Planned sale
Price
2.10
Quantity 97,982 -3.6%
Value US$205,762
3.7
Butler John P. CEO and President Executive Director
Transaction date
Planned sale
Price
2.10
Quantity 46,268 -1.7%
Value US$97,163
Grund Nicholas Officer Officer
Transaction date
Proposed sale
Price
2.10
Quantity 55,621
Value US$117,060
3.6
Burke Steven Keith Officer Officer
Transaction date
Proposed sale
Price
2.10
Quantity 50,506
Value US$106,295
3.7
Butler John P. Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.10
Quantity 144,250
Value US$303,589
3.5
Hadas Nicole R. SVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.26
Quantity 12,016 -1.8%
Value US$15,140
3.6
Dahan Michel SVP, Chief Operating Officer Officer
Transaction date
Planned sale
Price
1.26
Quantity 34,840 -4.9%
Value US$43,898
3.6
Dahan Michel Officer Officer
Transaction date
Proposed sale
Price
1.26
Quantity 34,840
Value US$43,818
3.5
Hadas Nicole R. Officer Officer
Transaction date
Proposed sale
Price
1.26
Quantity 12,016
Value US$15,113
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
1.58
Quantity 7,169 -1.0%
Value US$11,327
3.5
Hadas Nicole R. SVP, Chief Legal Officer Officer
Transaction date
Sale
Price
1.58
Quantity 5,974 -0.9%
Value US$9,439
3.6
Dahan Michel SVP, Chief Operating Officer Officer
Transaction date
Sale
Price
1.58
Quantity 8,661 -1.2%
Value US$13,684
3.7
Butler John P. CEO and President Executive Director
Transaction date
Sale
Price
1.58
Quantity 46,570 -2.2%
Value US$73,581
3.7
Butler John P. Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.58
Quantity 46,570
Value US$73,413
3.6
Burke Steven Keith Officer Officer
Transaction date
Proposed sale
Price
1.58
Quantity 7,169
Value US$11,301
3.6
Dahan Michel Officer Officer
Transaction date
Proposed sale
Price
1.58
Quantity 8,661
Value US$13,653
3.5
Hadas Nicole R. Officer Officer
Transaction date
Proposed sale
Price
1.58
Quantity 5,974
Value US$9,417
3.5
Hadas Nicole R. SVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.52
Quantity 7,411 -1.1%
Value US$11,265
3.7
Butler John P. CEO and President Executive Director
Transaction date
Sale
Price
1.52
Quantity 37,733 -1.8%
Value US$57,354
3.6
Dahan Michel SVP, Chief Operating Officer Officer
Transaction date
Sale
Price
1.52
Quantity 10,744 -1.5%
Value US$16,331
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.52
Quantity 8,367 -1.2%
Value US$12,718
3.5
Hadas Nicole R. Officer Officer
Transaction date
Proposed sale
Price
1.52
Quantity 7,411
Value US$11,245
3.6
Dahan Michel Officer Officer
Transaction date
Proposed sale
Price
1.52
Quantity 10,744
Value US$16,302
3.6
Burke Steven Keith Officer Officer
Transaction date
Proposed sale
Price
1.52
Quantity 8,367
Value US$12,695
3.7
Butler John P. Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.52
Quantity 37,733
Value US$57,252
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
1.68
Quantity 24,311 -3.3%
Value US$40,842
3.7
Butler John P. CEO and President Executive Director
Transaction date
Sale
Price
1.68
Quantity 46,489 -2.1%
Value US$78,102
3.7
Butler John P. Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.68
Quantity 46,489
Value US$77,957
3.6
Burke Steven Keith Officer Officer
Transaction date
Proposed sale
Price
1.68
Quantity 24,311
Value US$40,767
3.6
Burke Steven Keith SVP, Chief Medical Officer Officer
Transaction date
Sale
Price
1.15
Quantity 27,000 -3.9%
Value US$31,050
3.5
Hadas Nicole R. Officer Officer
Transaction date
Proposed sale
Price
1.22
Quantity 63,186
Value US$77,270
3.6
Dahan Michel Officer Officer
Transaction date
Proposed sale
Price
1.22
Quantity 95,478
Value US$116,760
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-01 2026-06-29 S Sale
Ostrowski Erik

SVP, CFO, CBO & Treasurer

Officer
93,061 -40.3%
391.03
US$4,036,686 		93,061 -40.3% 391.03 US$4,036,686
2026-06-29 2026-06-29 PrS Proposed sale
Ostrowski Erik

Officer

Officer
31,119
295.54
US$701,740 		31,119 295.54 US$701,740
2026-03-05 2026-03-04 B Purchase
3.7
Butler John P.

CEO and President

Executive Director
34,867 +35.9%
21.16
US$3,910,943 		34,867 +35.9% 21.16 US$3,910,943
2026-02-04 2026-02-02 PlS Planned sale
Malabre Richard C

SVP, Chief Accounting Officer

Officer
13,382 -4.3%
1.39
US$18,601 		13,382 -4.3% 1.39 US$18,601
2026-02-04 2026-02-02 PlS Planned sale
Grund Nicholas

Chief Commercial Officer

Officer
31,244 -5.3%
1.39
US$43,429 		31,244 -5.3% 1.39 US$43,429
2026-02-04 2026-02-02 PlS Planned sale
Rucci Carolyn M.

SVP, Chief Legal Officer

Officer
27,544 -4.5%
1.39
US$38,286 		27,544 -4.5% 1.39 US$38,286
2026-02-04 2026-02-02 PlS Planned sale
Rucci Carolyn M.

SVP, Chief Legal Officer

Officer
25,382 -4.0%
1.39
US$35,281 		25,382 -4.0% 1.39 US$35,281
2026-02-04 2026-02-02 PlS Planned sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
20,701 -2.1%
1.39
US$28,774 		20,701 -2.1% 1.39 US$28,774
2026-02-04 2026-02-02 PlS Planned sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
25,375 -2.6%
1.39
US$35,271 		25,375 -2.6% 1.39 US$35,271
2026-02-04 2026-02-02 PlS Planned sale
3.7
Butler John P.

CEO and President

Executive Director
83,689 -2.5%
1.39
US$116,328 		83,689 -2.5% 1.39 US$116,328
2026-02-04 2026-02-02 PlS Planned sale
3.7
Butler John P.

CEO and President

Executive Director
114,891 -3.5%
1.39
US$159,698 		114,891 -3.5% 1.39 US$159,698
2026-02-04 2026-02-02 PlS Planned sale
3.7
Butler John P.

CEO and President

Executive Director
96,065 -2.8%
1.39
US$133,530 		96,065 -2.8% 1.39 US$133,530
2026-02-04 2026-02-02 PlS Planned sale
Malabre Richard C

SVP, Chief Accounting Officer

Officer
13,382 -4.3%
1.39
US$18,601 		13,382 -4.3% 1.39 US$18,601
2026-02-04 2026-02-02 PlS Planned sale
Malabre Richard C

SVP, Chief Accounting Officer

Officer
36,142 -10.4%
1.39
US$50,237 		36,142 -10.4% 1.39 US$50,237
2026-02-04 2026-02-02 PlS Planned sale
Grund Nicholas

Chief Commercial Officer

Officer
31,244 -5.3%
1.39
US$43,429 		31,244 -5.3% 1.39 US$43,429
2026-02-04 2026-02-02 PlS Planned sale
Grund Nicholas

Chief Commercial Officer

Officer
53,585 -8.3%
1.39
US$74,483 		53,585 -8.3% 1.39 US$74,483
2026-02-04 2026-02-02 PlS Planned sale
Ostrowski Erik

SVP, CFO, CBO & Treasurer

Officer
34,951 -4.9%
1.39
US$48,582 		34,951 -4.9% 1.39 US$48,582
2026-02-04 2026-02-02 PlS Planned sale
Rucci Carolyn M.

SVP, Chief Legal Officer

Officer
27,544 -4.5%
1.39
US$38,286 		27,544 -4.5% 1.39 US$38,286
2026-02-04 2026-02-02 PlS Planned sale
Rucci Carolyn M.

SVP, Chief Legal Officer

Officer
25,382 -4.0%
1.39
US$35,281 		25,382 -4.0% 1.39 US$35,281
2026-02-04 2026-02-02 PlS Planned sale
Rucci Carolyn M.

SVP, Chief Legal Officer

Officer
16,846 -2.6%
1.39
US$23,416 		16,846 -2.6% 1.39 US$23,416
2026-02-04 2026-02-02 PlS Planned sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
20,701 -2.1%
1.39
US$28,774 		20,701 -2.1% 1.39 US$28,774
2026-02-04 2026-02-02 PlS Planned sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
25,375 -2.6%
1.39
US$35,271 		25,375 -2.6% 1.39 US$35,271
2026-02-04 2026-02-02 PlS Planned sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
21,582 -2.1%
1.39
US$29,999 		21,582 -2.1% 1.39 US$29,999
2026-02-04 2026-02-02 PlS Planned sale
3.7
Butler John P.

CEO and President

Executive Director
83,689 -2.5%
1.39
US$116,328 		83,689 -2.5% 1.39 US$116,328
2026-02-04 2026-02-02 PlS Planned sale
3.7
Butler John P.

CEO and President

Executive Director
114,891 -3.5%
1.39
US$159,698 		114,891 -3.5% 1.39 US$159,698
2026-02-04 2026-02-02 PlS Planned sale
3.7
Butler John P.

CEO and President

Executive Director
96,065 -2.8%
1.39
US$133,530 		96,065 -2.8% 1.39 US$133,530
2026-02-04 2026-02-02 PlS Planned sale
3.7
Butler John P.

CEO and President

Executive Director
46,660 -1.3%
1.39
US$64,857 		46,660 -1.3% 1.39 US$64,857
2026-02-02 2026-02-02 PrS Proposed sale
Ostrowski Erik

Officer

Officer
34,951
1.39
US$48,739 		34,951 1.39 US$48,739
2026-02-02 2026-02-02 PrS Proposed sale
Grund Nicholas

Officer

Officer
84,829
1.39
US$118,294 		84,829 1.39 US$118,294
2026-02-02 2026-02-02 PrS Proposed sale
3.6
Burke Steven Keith

Officer

Officer
67,658
1.39
US$94,349 		67,658 1.39 US$94,349
2026-02-02 2026-02-02 PrS Proposed sale
3.7
Butler John P.

Officer

Officer
341,305
1.39
US$475,950 		341,305 1.39 US$475,950
2026-02-02 2026-02-02 PrS Proposed sale
Rucci Carolyn M.

Officer

Officer
69,772
1.39
US$97,297 		69,772 1.39 US$97,297
2025-07-01 2025-06-30 PlS Planned sale
Ostrowski Erik

SVP, CFO, CBO & Treasurer

Officer
41,314 -7.6%
3.67
US$151,622 		41,314 -7.6% 3.67 US$151,622
2025-06-11 2025-06-09 PlS Planned sale
Malabre Richard C

SVP, Chief Accounting Officer

Officer
15,000 -5.3%
4.01
US$60,150 		15,000 -5.3% 4.01 US$60,150
2025-06-05 2025-06-04 PlS Planned sale
Malabre Richard C

SVP, Chief Accounting Officer

Officer
13,334 -4.8%
3.53
US$47,069 		13,334 -4.8% 3.53 US$47,069
2025-03-04 2025-03-03 PlS Planned sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
7,144 -0.9%
1.83
US$13,074 		7,144 -0.9% 1.83 US$13,074
2025-03-04 2025-03-03 PlS Planned sale
3.7
Butler John P.

CEO and President

Executive Director
46,409 -1.8%
1.83
US$84,928 		46,409 -1.8% 1.83 US$84,928
2025-03-03 2025-03-03 PrS Proposed sale
3.6
Burke Steven Keith

Officer

Officer
7,144
1.83
US$13,086 		7,144 1.83 US$13,086
2025-03-03 2025-03-03 PrS Proposed sale
3.7
Butler John P.

Officer; Director

Executive Director
46,409
1.83
US$85,007 		46,409 1.83 US$85,007
2025-02-04 2025-02-03 PlS Planned sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
27,236 -3.2%
2.10
US$57,196 		27,236 -3.2% 2.10 US$57,196
2025-02-04 2025-02-03 PlS Planned sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
23,270 -2.7%
2.10
US$48,867 		23,270 -2.7% 2.10 US$48,867
2025-02-04 2025-02-03 PlS Planned sale
Grund Nicholas

Chief Commercial Officer

Officer
55,621 -11.2%
2.10
US$116,804 		55,621 -11.2% 2.10 US$116,804
2025-02-04 2025-02-03 PlS Planned sale
Malabre Richard C

SVP, Chief Accounting Officer

Officer
30,202 -9.7%
2.10
US$63,424 		30,202 -9.7% 2.10 US$63,424
2025-02-04 2025-02-03 PlS Planned sale
3.7
Butler John P.

CEO and President

Executive Director
97,982 -3.6%
2.10
US$205,762 		97,982 -3.6% 2.10 US$205,762
2025-02-04 2025-02-03 PlS Planned sale
3.7
Butler John P.

CEO and President

Executive Director
46,268 -1.7%
2.10
US$97,163 		46,268 -1.7% 2.10 US$97,163
2025-02-03 2025-02-03 PrS Proposed sale
Grund Nicholas

Officer

Officer
55,621
2.10
US$117,060 		55,621 2.10 US$117,060
2025-02-03 2025-02-03 PrS Proposed sale
3.6
Burke Steven Keith

Officer

Officer
50,506
2.10
US$106,295 		50,506 2.10 US$106,295
2025-02-03 2025-02-03 PrS Proposed sale
3.7
Butler John P.

Officer; Director

Executive Director
144,250
2.10
US$303,589 		144,250 2.10 US$303,589
2024-05-14 2024-05-13 PlS Planned sale
3.5
Hadas Nicole R.

SVP, Chief Legal Officer

Officer
12,016 -1.8%
1.26
US$15,140 		12,016 -1.8% 1.26 US$15,140
2024-05-14 2024-05-13 PlS Planned sale
3.6
Dahan Michel

SVP, Chief Operating Officer

Officer
34,840 -4.9%
1.26
US$43,898 		34,840 -4.9% 1.26 US$43,898
2024-05-13 2024-05-13 PrS Proposed sale
3.6
Dahan Michel

Officer

Officer
34,840
1.26
US$43,818 		34,840 1.26 US$43,818
2024-05-13 2024-05-13 PrS Proposed sale
3.5
Hadas Nicole R.

Officer

Officer
12,016
1.26
US$15,113 		12,016 1.26 US$15,113
2024-03-01 2024-02-29 S Sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
7,169 -1.0%
1.58
US$11,327 		7,169 -1.0% 1.58 US$11,327
2024-03-01 2024-02-29 S Sale
3.5
Hadas Nicole R.

SVP, Chief Legal Officer

Officer
5,974 -0.9%
1.58
US$9,439 		5,974 -0.9% 1.58 US$9,439
2024-03-01 2024-02-29 S Sale
3.6
Dahan Michel

SVP, Chief Operating Officer

Officer
8,661 -1.2%
1.58
US$13,684 		8,661 -1.2% 1.58 US$13,684
2024-03-01 2024-02-29 S Sale
3.7
Butler John P.

CEO and President

Executive Director
46,570 -2.2%
1.58
US$73,581 		46,570 -2.2% 1.58 US$73,581
2024-02-29 2024-02-29 PrS Proposed sale
3.7
Butler John P.

Officer; Director

Executive Director
46,570
1.58
US$73,413 		46,570 1.58 US$73,413
2024-02-29 2024-02-29 PrS Proposed sale
3.6
Burke Steven Keith

Officer

Officer
7,169
1.58
US$11,301 		7,169 1.58 US$11,301
2024-02-29 2024-02-29 PrS Proposed sale
3.6
Dahan Michel

Officer

Officer
8,661
1.58
US$13,653 		8,661 1.58 US$13,653
2024-02-29 2024-02-29 PrS Proposed sale
3.5
Hadas Nicole R.

Officer

Officer
5,974
1.58
US$9,417 		5,974 1.58 US$9,417
2024-02-29 2024-02-27 PlS Planned sale
3.5
Hadas Nicole R.

SVP, Chief Legal Officer

Officer
7,411 -1.1%
1.52
US$11,265 		7,411 -1.1% 1.52 US$11,265
2024-02-29 2024-02-27 S Sale
3.7
Butler John P.

CEO and President

Executive Director
37,733 -1.8%
1.52
US$57,354 		37,733 -1.8% 1.52 US$57,354
2024-02-29 2024-02-27 S Sale
3.6
Dahan Michel

SVP, Chief Operating Officer

Officer
10,744 -1.5%
1.52
US$16,331 		10,744 -1.5% 1.52 US$16,331
2024-02-29 2024-02-27 PlS Planned sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
8,367 -1.2%
1.52
US$12,718 		8,367 -1.2% 1.52 US$12,718
2024-02-27 2024-02-27 PrS Proposed sale
3.5
Hadas Nicole R.

Officer

Officer
7,411
1.52
US$11,245 		7,411 1.52 US$11,245
2024-02-27 2024-02-27 PrS Proposed sale
3.6
Dahan Michel

Officer

Officer
10,744
1.52
US$16,302 		10,744 1.52 US$16,302
2024-02-27 2024-02-27 PrS Proposed sale
3.6
Burke Steven Keith

Officer

Officer
8,367
1.52
US$12,695 		8,367 1.52 US$12,695
2024-02-27 2024-02-27 PrS Proposed sale
3.7
Butler John P.

Officer; Director

Executive Director
37,733
1.52
US$57,252 		37,733 1.52 US$57,252
2024-02-02 2024-02-01 S Sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
24,311 -3.3%
1.68
US$40,842 		24,311 -3.3% 1.68 US$40,842
2024-02-02 2024-02-01 S Sale
3.7
Butler John P.

CEO and President

Executive Director
46,489 -2.1%
1.68
US$78,102 		46,489 -2.1% 1.68 US$78,102
2024-02-01 2024-02-01 PrS Proposed sale
3.7
Butler John P.

Officer; Director

Executive Director
46,489
1.68
US$77,957 		46,489 1.68 US$77,957
2024-02-01 2024-02-01 PrS Proposed sale
3.6
Burke Steven Keith

Officer

Officer
24,311
1.68
US$40,767 		24,311 1.68 US$40,767
2024-05-09 2023-08-25 S Sale
3.6
Burke Steven Keith

SVP, Chief Medical Officer

Officer
27,000 -3.9%
1.15
US$31,050 		27,000 -3.9% 1.15 US$31,050
2023-05-25 2023-05-25 PrS Proposed sale
3.5
Hadas Nicole R.

Officer

Officer
63,186
1.22
US$77,270 		63,186 1.22 US$77,270
2023-05-25 2023-05-25 PrS Proposed sale
3.6
Dahan Michel

Officer

Officer
95,478
1.22
US$116,760 		95,478 1.22 US$116,760
Explore more

More insider trading research around Akebia Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America